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Background: Clinical indicators are powerful tools to quantify the safety and quality of patient care. Their validity is often
unclear and definitions extremely heterogeneous. As part of the International Standardised Endpoints in Perioperative
Medicine (StEP) initiative, this study aimed to derive a set of standardised and valid clinical outcome indicators for use in
perioperative clinical trials.
Methods: We identified clinical indicators via a systematic review of the anaesthesia and perioperative medicine liter-
ature (PubMed/OVID, EMBASE, and Cochrane Library). We performed a three-stage Delphi consensus-gaining process
that involved 54 clinicianeresearchers worldwide. Indicators were first shortlisted and the most suitable definitions for
evaluation of quality and safety interventions determined. Indicators were then assessed for validity, reliability, feasi-
bility, and clarity.
Results: We identified 167 clinical outcome indicators. Participation in the three Delphi rounds was 100% (n¼13), 68%
(n¼54), and 85% (n¼ 6), respectively. A final list of eight outcome indicators was generated: surgical site infection at 30
days, stroke within 30 days of surgery, death within 30 days of coronary artery bypass grafting, death within 30 days ofEditorial decision: 12 April 2019; Accepted: 12 April 2019
© 2019 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.
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StEP initiative: clinical indicators - 229surgery, admission to the intensive care unit within 14 days of surgery, readmission to hospital within 30 days of surgery,
and length of hospital stay (with or without in-hospital mortality). They were rated by the majority of experts as valid,
reliable, easy to use, and clearly defined.
Conclusions: These clinical indicators can be confidently used as endpoints in clinical trials measuring quality, safety,
and improvement in perioperative care.
Registration: PROSPERO 2016 CRD42016042102 (http://www.crd.york.ac.uk/PROSPERO/display_record.php?
ID¼CRD42016042102).
Keywords: clinical trials; clinical indicators; quality improvement; outcome measures; patient safety; perioperative
medicine; standardised endpointEditor’s key points
 The Standardised Endpoints in Perioperative Medicine
(StEP) initiative was established to derive standardised
endpoints for use in perioperative clinical trials.
 After a systematic review and Delphi consensus pro-
cess, a set of eight outcome indicators was identified
that should be considered in designing future periop-
erative clinical trials.
 Use and reporting of these endpoints will support
improved benchmarking and meta-analysis of future
perioperative trials involving patient safety, quality and
improvement.Developed initially in the manufacturing industry, indicators
are increasingly used in hospitals to monitor organisational
performance or patient management.1 Clinical indicators are
specifically designed to measure the quality and safety of pa-
tient care.2 They are increasingly used in perioperative medi-
cine to drive improvement initiatives or assess the overall
quality of care provided.3
Clinical indicators can measure structure, process, or
outcome-related aspects of perioperative care.4,5 Structure
indicators measure organisational composition and resource
utilisation.2 Some examples include staffing levels, equip-
ment, and access to facilities (e.g. 24 h access to a fully staffed
emergency theatre). Process indicators measure the way care
is (or should be) delivered (e.g. prophylactic antibiotics
administration within 60 min before start of surgery).6,7
Outcome indicators measure patient-related results of care.
They occupy a prominent position in perioperative care as the
nature of clinical practice and its improvement largely relies
on measures of outcome.8 For example, only after the
demonstration that hospital-acquired infections are reduced
with preoperative administration of antibiotics within 60 min
can this administration become an evidenced-based patient
quality improvement recommendation. As such, an increas-
ingly larger number of outcome indicators have been devel-
oped to guide quality improvement initiatives in anaesthesia
and perioperative medicine9 where they are used as direct
measures of the quality and safety of care provided. They can
also be used in clinical trials as primary or secondary end-
points of interventions to improve patient-related quality and
safety of care within the perioperative setting.
Because there is limited academic interest in clinical in-
dicators and their use as outcome measures, there is a signifi-
cant lack of standardised definitions for this type of endpoints.For instance, according to the Australian Council on Healthcare
Standards (ACHS), an unplanned admission to the ICU, a pop-
ular and validated outcome indicator is ‘an unplanned admis-
sion to the Intensive Care Unit within 24 hours of a procedure
with an anaesthetist in attendance’, whereas for the Anaes-
thesia Quality Institute (USA), it is defined as ‘an unplanned
admission to the intensive care unit within 48 hours of induc-
tion’.10,11 In addition, only a limited number of indicators have
undergone a formal validation process,12 resulting in the use of
poorly defined and validated measures of outcomes.13
There is a need to identify and provide clearly defined,
reliable, and validated clinical outcome indicators that can be
used as endpoints in both perioperative clinical trials and
health services research assessing quality and safety
improvement initiatives.14 The Standardised Endpoints in
Perioperative Medicine (StEP) initiative is an international
collaboration with the aim of identifying a set of endpoints
supported by expert guidance and international consensus
for use in perioperative medicine trials. The current study
describes the results of a systematic literature review and
Delphi process to identify important outcome clinical
indicators.Methods
We used the standard method developed by the University of
California and the American Institute of research and devel-
opment.15,16 We undertook a systematic review of the litera-
ture followed by a Delphi consensus gathering process in order
to refine and validate a list of recommended clinical indicators
and their associated definitions.Inclusion/exclusion criteria and definitions
In the literature search we included only RCTs, quasi-
experimental trials or beforeeafter studies that reported in-
terventions to improve patient-related quality and safety of
care within the perioperative setting in adults >18 yr old. In-
terventions were defined as the implementation of best
medical practices, as developed locally or available through
best practice guidelines or protocols. To be considered for in-
clusion, studies also had to report the use of one or several
clinical indicators to measure intervention effectiveness
(outcome indicators).
Trials that assessed drug, device, or new procedure effec-
tiveness or reported adverse events as secondary outcomes
were excluded. We also did not consider studies that used
outcomes related exclusively to intensive care or surgical care
230 - Haller et al.and those reporting comfort measures (pain, postoperative
nausea and vomiting, sedation, immobility) or patient-
reported outcomes (quality of life, return to work, functional
assessment, satisfaction), as these were reviewed by other
groups of the StEP initiative. Detailed definitions used are
available in Supplementary material S2.Literature search and data extraction
We performed a systematic search on MEDLINE, EMBASE, and
the Cochrane Database for studies published between January
1, 2000 and March 30, 2016 in core clinical journals as defined
by the National Library of Medicine.17 To identify potentially
eligible studies according to title and abstract content, two
authors (GH and SB) independently performed the review with
the help of two professional librarians. The reference lists of
retrieved articles were also searched for additional studies. If
definitions of indicators in retrieved studies were poorly
defined, additional searches were performed using Web of
Science for abstracts of conferences, Google Scholar, profes-
sional organisations, and quality improvement initiatives
websites (grey literature) in order to retrieve original defini-
tions of those indicators. We did not apply any language re-
striction. A detailed description of the search strategies used is
provided in Supplementary material S3.
Selected articles were independently analysed by the two
authors, and clinical indicators were extracted according to a
standardised extraction and coding template (Supplementary
material S5). Redundancy between clinical indicators was
solved by aggregation into a single indicator and composite
measures were excluded. The overall process was performed
by two authors (GH, SB) during consensus meetings. Discrep-
ancies were resolved by consultation between these two au-
thors. Risk of bias in studies was not assessed, as the purpose
of the review was not assessing clinical intervention effec-
tiveness, but to identify the scope, definitions, and validity of
clinical indicators currently in use. Likewise, quantitative data
synthesis or meta-analysis was not performed.Delphi process
We used a Delphi method to gain consensus around the
clarity, reliability, and validity of each indicator as a measure
of patient quality in perioperative care to be used in future
clinical trials.18,19 The final list of retrieved clinical indicators
and associated definitions were provided to members of the
StEP Initiative Steering Committee, subgroup coordinators,
and members. These were expert researchers from different
anaesthesia specialties and countries (Australia, Canada, The
Netherlands, UK, USA, South Africa, Senegal, Switzerland; the
full list available in Supplementary material S1).Delphi round 1
After discussion with other subgroup members, the theme
subgroup chair (GH) prepared the initial list of endpoints and
associated definitions retrieved from the literature according
to a predefined format prepared by the StEP Steering Com-
mittee (Supplementary material S4). All members of the clin-
ical indicators subgroup (n¼8) and the StEP Steering
Committee (n¼5) were invited to participate.
Participants were asked to score each of the listed in-
dicators for clinical importance using a scale of 1e9. Scores of
1e3 indicated ‘not that important or invalid’, 4e6 indicated‘important but requires revision’, and 7e9 ‘critical for inclu-
sion’. Participants were offered the option to select ‘not
applicable/not sure’ if they were unable to form an opinion
about the importance or not of the clinical indicator. Partici-
pants had 2 weeks to answer before reminder emails (up to 3)
were sent to prompt completion of the survey. For each indi-
cator, participants were also invited to add any comments,
suggestions for modifications of existing definitions that they
believed were important. Individual indicator scores were
then calculated using mean, median, and range of scores.
Comments and suggestions provided by participants were
collated to be integrated to the second Delphi round.Delphi round 2
The theme subgroup chair (GH) selected indicators that had
been rated as ‘critical’ (score 7) by at least 70% of participants
to prepare the first list of indicators for Delphi round 2. In-
dicators rated as ‘not that important or invalid’ (score3) or as
‘important but requiring revision’ (score >3 and <7) by at least
70% of participants were also included in the second round but
clearly identified as such on a second list. Members of the
clinical indicators theme subgroup also discussed Delphi
round 1 results and indicators definitions and selection via
email.
Participants were asked to score the clinical indicators us-
ing the same questionnaire format and rating procedure as the
one used during Delphi round 1. For this second round, par-
ticipants were provided with the mean scores of each clinical
indicator after round 1. Comments after Delphi round 1 were
also added. This stage included the entire StEPWorking Group
(n¼54).Delphi round 3
The theme subgroup Chair (GH) selected for Delphi round 3
only indicators that had been rated as ‘critical’ (score 7) by at
least 70% of participants during the second round. Indicators
rated as ‘not that important or invalid’ (score3) or ‘important
but requiring revision’ (score >3 and <7) were not included. If
responses to the second-stage Delphi process comments sec-
tion suggested that modification to endpoint definitions or
rating had to be made, this was discussed within the in-
dicator’s theme subgroup via email.
For this third round, participants were provided with the
short list of selected indicators and attached definitions and all
comments provided after rounds 1 and 2. They were asked to
score the item using a second questionnaire (pro forma
available in Supplementary material S5). The questionnaire
included four rating criteria per indicator:20,21
1. Validitydthe degree to which the indicator measures what
it purports to measure
2. Reliabilitydthe degree of stability of the indicator when
measurement is repeated under identical conditions
3. Feasibilitydpracticability/ease of use in the clinical setting
4. Clarity of the definitiondthe degree to which the clinical
indicator meaning can be easily understood
For each question, participants were again asked to rate
each indicator on a 1 to 9 scale with scores 1e3 indicating ‘no’,
4e6 meaning ‘unsure’, 7e9 meaning ‘yes’; meanwhile, a score
of 10 meant ‘not assessable’.
At the end of the third Delphi round, indicators that had a
score of 7e9 (‘yes’) for each question were automatically
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in clinical trials. Clinical indicators rated 4e6 (‘unsure’) for one
or several of the four rating criteria were discussed by email
within the indicator’s subgroup. Those that had a score of 1e3
(‘no’) for any of the rating criteria were considered only as
optional, but not recommended.
Each Delphi round was coordinated by the Department of
Anaesthesia and Perioperative Medicine at the Alfred Hospital
in Melbourne, Australia. Participants’ answers to the different
Delphi rounds were recorded, transformed and analysed using
the statistical Package for Social Sciences (SPSS©, New York).
Analyses included mean, median, number, and proportion of
respondents.Results
A total of 20 058 reports were identified, of which 351 were
selected for further analyses. After full content assessment
and exclusion of duplicates, observational studies, costs
analysis studies, surgical, new technique, or drug-related
studies, 120 reports were considered. Of these, 16 further
publications were excluded as no information and definition
of any quality indicator was provided. The final analysis
included 104 reports and 167 clinical indicators (Fig. 1). The full
list of clinical indicators identified is provided in
Supplementary material S6.Fig 1. Flow diagram of literature search for systematic reviews of stu
indicators as study outcome.After full assessment and consensus by the two raters (GH,
SB), the final list was reduced to 101 indicators after removal of
additional duplicates, composite scores, ICU, and surgical in-
dicators and outcome measures that were assessed by other
StEP-COMPAC Groups. The final list was carried forward to the
Delphi process. Participation to the different Delphi rounds
was 100% (n¼13), 68% (n¼54), and 85% (n¼6), respectively. Re-
sults of the Delphi rounds 1, 2, and 3 are shown in Table 1.
None of the 101 indicators selected in the first Delphi round
were removed for the second Delphi round. For the third
Delphi round, all clinical indicators rated as important by
more than 70% of the participants were carried forward
except: ‘Pulmonary embolism within 30 days of surgery’,
‘Myocardial infarction within 30 days of surgery’, ‘Myocardial
infarction within 30 days of surgery (with or without in-
hospital mortality)’, and ‘Major adverse cardiac event within
30 days of surgery’ (available in Supplementary material S7).
These indicators were considered by several subgroup chairs
and Delphi participants as redundant with outcomes assessed
by other subgroups or too poorly defined to allow further
assessment.
The final list included eight clinical indicators rated for
validity, reliability, usability, and clarity of definitions, and is
provided in Table 2. All indicators except ‘Surgical Site
Infection rate at 30 days after surgery according to CDC
criteria’ were considered by at least 50% of the experts asdies assessing quality improvement initiatives and using clinical
Table 1 Results of the three Delphi rounds. ncf, not carried forward; N, total number; (%) proportion



















1. Absence of falls after surgery 0 6 30 2 4 17 e ncf e
2a. Surgical site infection (definition 1) 1 7 70 1 7 65 e ncf e
2b. Surgical site infection (definition 2) 2 7 53 0 5 20 e ncf e
2c. Surgical site infection (definition 3) 1 6.5 46 0 5 0 e ncf e
2d. Surgical site infection (definition 5) 1 6.5 46 0 5 6 e ncf e
2e. Surgical site infection 0 8 92 0 8 89 0 8 92
3a. Wound infection within 30 (or 90)
days of surgery (definition 1)
2 7 46 0 5 16 e ncf e
3b. Wound infection within 30 (or 90)
days of surgery (definition 2)
2 7 61 0 6 38 e ncf e
3c. Wound infection within 30 (or 90)
days of surgery (definition 3)
3 7 46 0 5.5 27 e ncf e
3d. Wound infection within 30 (or 90)
days of surgery (definition 4)
1 7 61 0 6 34 e ncf e
4. Number of patients who received
antibiotics beyond the recommended
postoperative period
2 5 15 1 4 7 e ncf e
5. Quality of laryngoscopy and tracheal
intubation
1 5 30 1 3 0 e ncf e
6a. Acute postoperative renal
dysfunction (definition 1)
1 6 46 3 5.5 19 e ncf e
6b. Acute postoperative renal
dysfunction (definition 2)
0 6 46 2 6 45 e ncf e
6c. Acute postoperative renal
dysfunction (definition 3)
1 4.5 0 1 4 8 e ncf e
6d. Acute postoperative renal
dysfunction (definition 4)
1 7 53 2 5.5 30 e ncf e
6e. Acute postoperative renal
dysfunction (definition 5)
0 6 38 2 6 21 e ncf e
7. Acute stroke after carotid
endarterectomy
0 6 46 2 6 31 e ncf e
8a. Stroke within 30 days of surgery
(definition 1)
0 6 23 1 6 39 e ncf e
8b. Stroke within 30 days of surgery
(definition 2)
0 7 92 1 8 90 0 7 92
9. Inadequate regional block 1 7 53 1 5 21 e ncf e
10. Failed regional block 0 7 61 1 5 21 e ncf e
11. Failed spinal block 2 4.5 15 1 4 3 e ncf e
12. Failed epidural 0 7 53 1 5 9 e ncf e
13. Unintended epidural vessel
penetration
0 6 23 1 5 9 e ncf e
14. Incomplete epidural block 0 7 46 1 5 19 e ncf e
15. Very high or total spinal block as a
result of accidental intrathecal
injection
0 6 38 1 6 23 e ncf e
16a. Postdural puncture headache
(definition 1)
1 6 30 1 5.5 16 e ncf e
16b. Postdural puncture headache
(definition 2)
2 7 38 1 6 23 e ncf e
16c. Postdural puncture headache
(definition 3)
1 7 46 1 7 53 e ncf e
17a. Number of intubation attempts
(definition 1)
0 7 46 2 5.5 28 e ncf e
17b. Number of intubation attempts
(definition 2)
1 5 7 2 4 3 e ncf e
18. Failed attempt of intubation 2 6 30 2 5 17 e ncf e
19. Mucosal trauma after intubation 1 4.5 15 2 5 9 e ncf e
20. Postoperative hoarseness 0 6 30 1 5 13 e ncf e
21. Recovery room airway complications 0 6 23 2 5 9 e ncf e
22. Intraoperative airway complications 0 6 23 2 5 13 e ncf e
23. Vocal cord injuries 1 6.5 38 2 6 41 e ncf e
24. Composite pharyngolaryngeal
adverse events
0 6 38 2 6 31 e ncf e
Continued
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25. Securement of an effective airway 0 6 38 2 5 15 e ncf e
26. Hypoxia during mask ventilation or
tracheal intubation
0 6 30 1 5 12 e ncf e
27. Bronchial injuries 1 4.5 7 1 4 3 e ncf e
28. Postoperative respiratory failure 0 7 61 1 7 69 e ncf e
29. Pulmonary complications 0 6 38 2 6 31 e ncf e
30. Pulmonary embolism within 30 days
of surgery
0 7 69 1 7 73 e ncf e
31. Prolonged mechanical ventilation 0 7 61 0 7 59 e ncf e
32. Venous thromboembolism 0 7 61 1 7 69 e ncf e
33. Atelectasis within 14 days 0 5 15 0 4 3 e ncf e
34. Pneumonia within 30 days of surgery 0 7 84 0 7 67 e ncf e
35. Aspiration of gastric content 1 6 38 1 6 37 e ncf e
36. Proportion of transfused patients 0 6 38 2 7 50 e ncf e
37. Risk of receiving any fresh frozen
plasma in-hospital
1 6 15 1 5.5 23 e ncf e
38a. Awareness (definition 1) 0 6 30 2 6 41 e ncf e
38b. Awareness (definition 2) 1 6 38 2 6 39 e ncf e
39a. Time to orientation (definition 1) 0 6 46 2 5 0 e ncf e
39b. Time to orientation (definition 2) 1 6 23 1 5 0 e ncf e
40. Postoperative CNS failure 3 4 23 1 5 16 e ncf e
41. Postoperative cardiocirculatory
failure
1 4 23 2 4 16 e ncf e
42. New postoperative deterioration in
neuropsychologic performance
1 5 30 1 5 16 e ncf e
43. Postoperative residual curarisation 0 6 38 2 6 26 e ncf e
44. Reoccurrence of neuromuscular
blockade
0 6 23 3 6 23 e ncf e
45. Recovery of the train of four ratio 0 5 23 3 5 7 e ncf e
46. Perioperative hypothermia
(definition 1)
0 7 53 2 7 57 e ncf e
47. Postoperative hypothermia
(definition 2)
0 6 46 2 6 45 e ncf e
48. Surgeon satisfaction 0 4 30 2 4 3 e ncf e
49. Surgical conditions for thoracic
surgery
0 6 46 2 4 6 e ncf e
50. Surgical space conditions 0 6 38 2 4.5 3 e ncf e
51. Hypoglycaemic events 0 7 69 1 7 67 e ncf e
52. Incidence of postoperative delirium
during the postoperative
hospitalisation period
0 6 46 2 7 68 e ncf e
53. Postoperative haematology failure 2 6 15 4 4 3 e ncf e
54. Postoperative hepatic failure 0 5 23 3 5 10 e ncf e
55. Cardiac arrest within 30 days of
surgery Rating
1 7 53 1 7 59 e ncf e
56. Non-fatal cardiac arrest 0 7 76 1 7 65 e ncf e
57. Non-fatal myocardial infarction 1 7 53 2 7 63 e ncf e
58. New myocardial ischaemia 1 6.5 46 1 7 55 e ncf e
59. New clinically important atrial
fibrillation
1 7 69 1 7 66 e ncf e
60a. Myocardial infarction within 30
days of surgery (definition 1)
1 7 69 1 7 75 e ncf e
60b. Myocardial infarction within 30
days of surgery (definition 2)
0 7 61 1 7 77 e ncf e
60c. Myocardial infarction within 30
days of surgery
2 8 46 1 6 47 e ncf e
61. Major adverse cardiac event within
30 days of surgery
0 7 61 1 7 77 e ncf e
62. Cardiovascular death within 12
months of surgery
0 6 46 2 6 31 e ncf e
63. 30 daymortality after coronary artery
bypass grafting
1 8 84 2 8 87 1 8 84
64. Adjusted 30 day mortality after
carotid endarterectomy
1 7 61 1 6 35 e ncf e
Continued
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65. Number of patients who died or
experienced complications until
hospital discharge
0 7 53 1 7 58 e ncf e
66a. Operative mortality (definition 1) 1 7 61 0 7 68 e ncf e
66b. Operative mortality (definition 2) 1 8 70 0 8 80 1 8 70
67. Incidence of 30 day overall
postoperative morbidity
2 6 38 1 6 39 e ncf e
68. Postoperative major complications
(in-hospital or within 30 days)
1 7 53 0 7 57 e ncf e
69. Severe hypotension 2 6 30 0 5 20 e ncf e
70. Severe nausea and vomiting 2 6 38 2 6 21 e ncf e
71. Sum of all prespecified complications 3 4.5 7 0 4 10 e ncf e
72. Postoperative morbidity 1 7 69 0 6 42 e ncf e
73. Safe to discharge from the surgical
suite
1 7 69 3 6 41 e ncf e
74. Time to eligibility for PACU discharge 1 6 38 3 6 37 e ncf e
75. Time to fulfilment of criteria for
leaving the operating room
1 6 38 2 6 23 e ncf e
76. Admission to the intensive care unit
within 14 days
1 7 61 1 7 76 1 7 76
77. Eligibility to bypass the PACU, i.e.
‘fast tracking’
1 6.5 46 3 6 20 e ncf e
78. Readmission to ICU or IMC
(Immediate Care Unit)
2 7 53 0 7 69 e ncf e
79. Need for patient readmission 1 8 92 0 8 92 1 8 92
80a. Length of stay (definition 1) 2 7 76 0 7 75 2 7 76
80b. Length of stay (definition 2) 3 8.5 61 0 8 77 3 8.5 61
234 - Haller et al.valid (score 7). The same rating (score 7) for reliability
was provided for all indicators except ‘Surgical Site Infection
rate at 30 days after surgery according to CDC criteria’ and
‘stroke within 30 days of surgery’. The majority of experts
(50%) also rated the final list of indicators as easy to use
(score 7) and the selected endpoints as having clear defi-
nitions except ‘admission to the intensive care unit within
14 days’.Discussion
After a systematic review and Delphi process to achieve
consensus from a broad range of experts involved in periop-
erative clinical studies, we identified eight key clinical in-
dicators to measure effectiveness of interventions (i.e. best
practice protocols and guidelines) aimed at improving quality
and s
Identification of a list of outcome indicators used as end-
points in trials through a systematic search of existing litera-
ture is an important step in the process of standardising
endpoint measures for trials assessing quality and safety
improvement initiatives. However for these outcome in-
dicators to be reliably used for such purpose, they need first to
have relevance for the clinical context in which they are used.
We therefore asked panel experts to prioritise indicators for
their use in the clinical setting and to agree on the most
appropriate definitions. Secondly, as true quality and safety
indicators need to reflect the care provided rather than pre-
existing diseases, we asked experts to assess these in-
dicators for their likelihood to reflect an issue in the quality of
care provided. We used a methodology developed in social
sciences: face validation.21Face validity testing is based on field expert consensus.15,22
Field experts literally ‘look’ at the indicator and agree not only
on its definition and meaning and but also validity. This is
done through a consensus development process, where ex-
perts discuss meaning and definitions of clinical indicators.
For this study we used the Delphi method. This entire stand-
ardised process has been developed and validated by the
University of California and the American Institute of research
and development.16 As a result of this iterative process, eight
clinical outcome indicators were selected, their definitions
clarified, and their ‘face’ validity confirmed for nearly all in-
dicators. These indicators refer to harmful events likely to be
caused by the care provided rather than by pre-existing dis-
ease in line with the WHO definition of patient safety ‘the
absence of preventable harm to a patient during the process of
health care’.23 In addition, a number of them relate to patient
trajectories in hospital such as readmission to hospital, un-
planned admission to ICU, and length of stay. This reinforces
the likelihood of unexpected events related to care provided
that may have led to prolonged stay or unexpected admission
to ICU or hospital.
Most of these indicators were also considered by experts as
reliable, clearly defined, and usable as endpoints in clinical
trials assessing quality improvement interventions.
While a large number of clinical indicators is available in
the literature or within lists provided by hospital accreditation
bodies, their level of validity is often limited and definitions
are often lacking or sometimes conflicting. Heterogeneity in
outcome definitions can significantly impact on the reliability
of clinical trials performed in the area and limit further
development of scientific evidence to guide improvement
initiatives.24 It can also limit comparison between studies and
Table 2 Results of the final Delphi round on validity, reliability, feasibility, and clarity of definitions of selected indicators. *CDC criteria: a surgical site infection (SSI) is an infection that
occurs after surgery in the part of the body where the surgery took place. Surgical site infections can sometimes be superficial infections involving the skin only. Other surgical site
infections are more serious and can involve tissues under the skin, organs, or implanted material. Symptoms include: Redness and pain around the area where you had surgery;
Drainage of cloudy fluid from your surgical wound; Fever. yValidity. Does the endpoint measures what it purports to measure? zReliability. Is the endpoint reproducible and does it have
stability whenmeasurement is repeated under identical conditions? ¶Feasibility. Can the endpoint data be collected and used easily by research staff with some training, without undue
effort or risk of missing data? xClarity of the definition. Does the endpoint have a meaning that can be easily understood?
Clinical indicator’s generic name and
definition
Validityy Reliability‡ Feasibility¶ Clarity of the definition§
Unsure (n) Median
score
Score ≥7 (%) Unsure (n) Median
score
Score ≥7 (%) Unsure (n) Median
score




Surgical site infection rate at 30 days after
surgery according to CDC criteria*
4 5.5 16 4 5 16 2 6 50 2 7 66
Stroke within 30 days of surgery
Cerebral haemorrhage on CT or MRI, or new
neurological signs (paralysis, weakness, or
speech difficulties) lasting 24 h or leading
to earlier death
2 6 50 3 5.5 33 2 7 66 1 7.5 83
30 day mortality after coronary artery
bypass grafting
Death within 30 days of coronary artery
bypass grafting
3 6.5 50 1 8 83 0 8 100 0 8.5 100
Operative mortality
Death within 30 days of surgery
2 7 66 1 7.5 83 0 8 100 0 8 100
Admission to the intensive care unit
within 14 days
Admission to ICU within 14 days of surgery
and not part of the postoperative care
3 6.5 50 3 6.5 50 3 6.5 50 4 6 33
Need for patient readmission
Readmission to hospital within 30 days of
surgery
0 7.5 100 1 7.5 83 0 7.5 100 1 7.5 83
Length of stay (LOS)
LOS defined as the postoperative hospital LOS
and calculated by subtracting using date of
hospital discharge to date of surgery
3 6.5 50 3 6 50 0 7 100 1 7 83
Length of stay
LOS is defined as the number of days from the
day of surgery to hospital discharge or
death





















236 - Haller et al.further combination of studies in meta-analyses.25 We tried to
identify a usable list of relevant clinical outcome indicators
that are clearly defined, reliable, and valid as quality and
safety measurement tools to be used in clinical trials and
health services research addressing patient quality and safety
issues. It should be emphasised that the feasibility of
measuring a specific endpoint in any trial will also depend on
other factors that were not specifically measured in this study
and that could still hinder use of the recommended indicators.
These include especially the complexity of the clinical trial
and the available budget. Although many endpoints and in-
dicators can be recommended, it is ultimately the workload to
collect them and the available budget to do so that will decide.
Several limitations of this study have to be mentioned. First
is themethods used. Because it is based on a systematic review,
it only enables identification and rating of existing indicators.
We did not develop a list of new indicators for future use as
endpoints in perioperative trials. However, an advantage of the
chosen method is that indicators for which consensus defini-
tions are achieved will be immediately available, enabling re-
searchers and clinicians to derive more value and applicability
from findings of published perioperative research.
Second is that clinical indicators often refer to post-
operative complications. They can consequently easily be
confused with broader clinical trials outcome measures such
as postoperative respiratory failure or acute postoperative
myocardial infarct. This may lead to some confusion as to the
specificity of selected indicators for quality and safety mea-
surement. To limit this risk, we used strict inclusion criteria
and selected only reports of interventions that aimed specif-
ically at improving patient-related quality and safety of care
within the perioperative setting. To identify these indicators
we used search terms that directly related to quality and safety
such as ‘iatrogenic complications’, ‘adverse drug reaction’,
and ‘complication avoidance’. We also asked panel experts
whether ‘faced with the indicator’ they could conclude that it
was a valid, reliable, usable, and clearly defined measure of
patient quality and safety in perioperative medicine.
Third is that the purpose of the StEP international initiative
was to identify and provide straightforward, clinically sensi-
ble, and valid consensus definitions for a comprehensive set of
trial endpoints.26 As a result, there was some overlap between
the different outcomes identified by the different subgroups
participating in the initiative. This was the case in our study
for outcomes related to postoperative complications (e.g.
aspiration), that could be interpreted as conventional outcome
measures whereas they can also relate to quality and safety.
To solve this issue, discussions took place during the Delphi
process between subgroup chairs to reach a consensus be-
tween groups as to which group should assess overlapping
endpoints.
Fourth is that for ‘Surgical Site Infection rate at 30 days
after surgery according to CDC criteria’ both validity and reli-
ability were limited. Only 16% of the experts provided a score
7 for validity and reliability. This was not because experts
found that association with quality was unclear. Nosocomial
infection is a valid and worldwide used clinical indicator.
However, they found that the definition of an infection
through ‘redness and pain with cloudy fluid secretion’was not
specific and the risk of misdiagnosis was high. As a result we
recommend its use as an endpoint for quality and safety
measurement with some caution.
Fifth is that our literature searchwas limited to core clinical
journals. Although this approach increased the likelihood ofretrieving the most clinically relevant and read publications, it
limited at the same time the scope of the literature search
process.
Finally, as for any diagnostic tool in medicine, specificity of
measurement tools (here clinical indicators) rarely reaches
100%. In our study, only ‘readmission to hospital within 30
days of surgery’ was considered by 100% of the experts ques-
tioned as having very high validity. For all other endpoints, the
highest level of validity was attributed by experts in 16%e66%
of the cases, depending on the indicator assessed. This sug-
gests that these indicators may also in some circumstances
measure other dimensions of care (i.e. patient decision to
leave hospital earlier than recommended; severe pre-existing
disease leading to early postoperative mortality). However, in
most other cases, the outcome indicators identified can be
confidently used as endpoints in clinical trials and health
services research assessing patient quality and safety
improvement initiatives.
Despite these limitations, we identified a number of
standardised endpoints for quality and safetymeasurement to
be used in future studies assessing effectiveness of in-
terventions aimed at improving medical practices through
best practice guidelines or protocols. This study should
improve both consistency in the use of perioperative clinical
indicators and reliability of clinical trial results. This should
translate into improved interpretation of study results and
better translation into clinical practise.StEP Steering Committee members
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